Начало › Нон-Ходжкинов лимфом › Ню Йорк › New York City
Клинични проучвания за Нон-Ходжкинов лимфом в New York City, NY
31 проучвания за Нон-Ходжкинов лимфом търсят участници в обекти в и около New York City (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Набиране на участнициФаза 1/2
- Columbia University Medical Center, New York
- Weill Cornell Medical College Newyork Presbyterian Hospital, New York
- Memorial Sloan Kettering Cancer Center Mskcc, New York
Epco, Zanu, Ritux for R/R FL or MZL
Набиране на участнициФаза 2
- Memorial Sloan Kettering Cancer Center, New York
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Набиране на участнициФаза 2
- Manhattan Eye, Ear, and Throat Hospital, New York
- Staten Island University Hospital, New York
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Набиране на участнициФаза 1
- New York University (NYU) Clinical Cancer Center, New York
- Weill Cornell Medicine, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Набиране на участнициФаза 1
- Columbia University, New York
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Набиране на участнициФаза 1
- Memorial Sloan Kettering Cancer Center, New York
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
Набиране на участнициФаза 1
- Cornell, New York
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Набиране на участнициФаза 1/2
- Research Site, New York
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
Набиране на участнициФаза 1/2
- Local Institution - 0037, New York
- Memorial Sloan Kettering Cancer Center, New York
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Набиране на участнициФаза 2
- Research Site, New York
Cord Blood Transplant in Adults With Blood Cancers
Набиране на участнициФаза 2
- Memorial Sloan Kettering Cancer Center, New York
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
Набиране на участнициФаза 1
- Columbia University Irving Medical Center/New York Presbyterian Hospital, New York
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
Набиране на участнициФаза 1
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
Набиране на участнициФаза 1
- Clinical Trial Site, New York
- Clinical Trial Site, New York
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Набиране на участнициФаза 1/2
- Research Site, New York
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Набиране на участнициФаза 1/2
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Набиране на участнициФаза 1/2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Набиране на участнициНаблюдателно проучване
- Weill Cornell Medical Center (Data Analysis Only), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
DALY II USA/ MB-CART2019.1 for DLBCL
Набиране на участнициФаза 2
- Memorial Sloan Kettering Cancer Center, New York
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Набиране на участнициФаза 1
- Memorial Sloan Kettering Cancer Center, New York
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Набиране на участнициНаблюдателно проучване
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital at Cornell, New York
- Mount Sinai Medical Center - New York, New York
- и още 3
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Набиране на участнициФаза 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Набиране на участнициФаза 1/2
- Mt Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
Набиране на участнициФаза 2
- Memorial Sloan Kettering Cancer Center, New York
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
Набиране на участнициФаза 2
- Icahn School of Medicine at Mount Sinai, New York
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Набиране на участнициФаза 4
- Memorial Sloan-Kettering Cancer Center (MSKCC) - New York, New York
- Memorial Sloan-Kettering Cancer Center (MSKCC) - New York, New York
- Memorial Sloan-Kettering Cancer Center (MSKCC) - New York, New York
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Набиране на участнициФаза 4
- Memorial Sloan-Kettering Cancer Center (MSKCC) - New York, New York
Study of SGR-1505 in Mature B-Cell Neoplasms
Набиране на участнициФаза 1
- Weill Cornell, New York
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
Набиране на участнициРанна фаза 1
- Memorial Sloan Kettering Cancer Center, New York
Amping up With PemJAK
Набиране на участнициФаза 2
- Columbia University Irving Medical Center, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набиране на участнициНаблюдателно проучване
- Massive Bio SYNERGY-AI site, New York
Проучвания за Нон-Ходжкинов лимфом в други градове
- Houston, TX31 проучвания
- Boston, MA26 проучвания
- Nashville, TN21 проучвания
- Philadelphia, PA20 проучвания
- Baldwin Park, CA19 проучвания
- Washington, DC18 проучвания
- Chicago, IL18 проучвания
- Atlanta, GA18 проучвания
- Milwaukee, WI18 проучвания
- Columbus, OH18 проучвания
- Dallas, TX17 проучвания
- Seattle, WA16 проучвания
Други проучвания в New York City
- Рак на гърдата136 проучвания
- Рак на белия дроб с недребноклетъчен тип121 проучвания
- Рак (всички видове)109 проучвания
- Рак на простатата103 проучвания
- Метастатичен рак93 проучвания
- Колоректален рак78 проучвания
- Рак на яйчниците69 проучвания
- Рак на белия дроб60 проучвания
- Множествен миелом60 проучвания
- Рак на панкреаса60 проучвания
- Ендометриален рак52 проучвания
- Остра миелоидна левкемия51 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.